[Analysis of the etiological structure of sexually transmitted infections and immunological responsiveness in women with papillomavirus infection of the cervix uteri].
Shevchenko, E A; Uspenskaia, O A.
; 54(4): 37-9, 2009.
Artigo em Russo | MEDLINE | ID: mdl-19708554
Reduction in HPV16/18 prevalence among young women with high-grade cervical lesions following the Japanese HPV vaccination program.
A Prize for Cancer Prevention.
Cervical Local Immune Response for High-Risk Human Papillomavirus Infection: Involvement With Cervical Mucus SLPI Proteins.
Management of HPV-positive women in cervical screening using results from two consecutive screening rounds.
Stratifying HPV-positive women for CIN3+ risk after one and two rounds of HPV-based screening.
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Identification of human papillomaviruses from formalin-fixed, paraffin-embedded pre-cancer and invasive cervical cancer specimens in Zambia: a cross-sectional study.
Human papillomavirus genotypes in women with invasive cervical cancer with and without human immunodeficiency virus infection in Botswana.
The 16, 18, and 45 HPV infection in high grade squamous cervical lesions in primary hr-HPV test screening program.
Prognostic factors for spontaneous regression of high-risk human papillomavirus-positive cervical intra-epithelial neoplasia grade 2.